Vaccination with tumor-ganglioside glycomimetics activates a selective immunity that affords cancer therapy
Vaccination with tumor-ganglioside glycomimetics activates a selective immunity that affords cancer therapy
| Download | |
|---|---|
| DOI | Resolve DOI: https://doi.org/10.1016/j.chembiol.2019.03.018 |
| Author | Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: |
| Affiliation |
|
| Format | Text, Article |
| Subject | ganglioside; glycomimetic; immunity; vaccine; cancer therapy |
| Abstract | |
| Publication date | 2019-05-16 |
| Publisher | Elsevier Cell Press |
| Licence |
|
| In | |
| Language | English |
| Peer reviewed | Yes |
| NRC number | NRC-HHT_53421 |
| Export citation | Export as RIS |
| Report a correction | Report a correction (opens in a new tab) |
| Record identifier | 20aa9f9e-4b76-4246-8cb4-3dd6e091ba2a |
| Record created | 2020-12-08 |
| Record modified | 2021-09-24 |
- Date modified: